GBA-LRRK2 Parkinson’s Disease: a clinical case
Objective: Description of the phenotype of a Parkinson’s disease (PD) patient carrying mutations in both GBA and LRRK2 genes. Background: Monogenic PD due to LRRK2…The Efficacy and Safety of Subcutaneous Apomorphine in Patients with Parkinson’s Disease: A Meta-Analysis Randomized Controlled Trials
Objective: The objective of this study to evaluate the efficacy and safety of subcutaneous apomorphine for patients with Parkinson’s disease (PD). Background: Subcutaneous apomorphine has…Does Transcranial Direct Current Simulation Improve Motor Functions in Patients with Parkinson’s disease?
Objective: The aim of this meta-analysis is to investigate the impact of active tDCS on motor function in patients with PD. Background: Parkinson’s disease (PD)…Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson’s disease is safe and may be advantageous
Objective: We describe a case series of 12 patients requiring administration of levodopa-carbidopa intestinal gel (LCIG) who had their tube placed by per-oral image guided…Clinical Associations of Hand Deformities in Parkinson´s Disease
Objective: Objective: We aimed to correlate hand deformities in patients with Parkinson´s disease (PD) with demographics, motor status and other parkinsonian postural abnormalities in order to…Longitudinal assessment of genetic determinants of cognitive decline in Parkinson’s disease
Objective: This study aimed to investigate the relationships between genetic variants reportedly associated with neurological disease and cognitive decline, in patients with PD over a…“Familial imprint” of Parkinson disease: the siblings’ cohort of PROPAG-AGEING
Objective: To verify if non-affected siblings (Sibs) of PD patients share candidate PD biomarkers in comparison with de-novo PD patients (PD) and healthy controls (HC).…Longstanding cervical dystonia followed by parkinsonism – coincidence, risk factor or syndromic association?
Objective: To describe the occurence of parkinsonism after longstanding dystonia in a cohort of patients followed for long periods in our botulinum toxin injection clinic.…Neuroprotective effect of Yerba mate (Ilex paraguariensis) in a Drosophila model of Parkinson ’s disease
Objective: To test the neuroprotective capacity of Yerba Mate (YM) in an in vivo model of Parkinson's disease. Background: Parkinson's disease (PD) is caused by the…The prevalence of ICBs in patients treated with apomorphine infusion: a retrospective analysis
Objective: To assess the prevalence of impulsive compulsive behaviours (ICBs) in Parkinson’s disease who donated their brains and used apomorphine infusion in life. Background: Impulsive…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.